Gonna hang on to see how the plan pans out.
Fiscal Year 2017 Highlights:
Record net sales of $16.9 million, an increase of .6% from the prior year.
Record gross profit of $4.9 million, an increase of $.7 million, or 17%, from the prior year.
$736,000 in income from operations, compared to income from operations of $147,000 in the prior year.
Net income of $203,000 compared to a net loss of $312,000 in the prior year.
Adjusted EBITDA of $975,000, a 139% increase from $408,000 in the prior year.
Management Commentary
"During fiscal 2017 we experienced strong growth in sales of our manufactured products, including a 52% increase in Jaxx and Avana branded products, and a significant improvement in our gross profit margins," said Luvu Brands President and CEO, Louis Friedman. "Our focus in fiscal 2018 is on continuing to improve our production efficiencies and gross profit margins and ramping up production in order to keep pace with the continued strong demand", added Mr. Friedman.
https://www.otcmarkets.com/stock/LUVU/news/Luvu-Brands-Reports-Record-Net-Sales-and-Net-Income?id=171646&b=y
Jan 20, 2017
As part of this plan, and in an effort to reduce staff, shipping expense, inventory, and rationalize our SKU count, Mr. Friedman added, "By the end of January, 2017 we will phase-out and no longer distribute products from Tenga Japan, including their male pleasure products and personal massagers. For the three months ended December 31, 2016, sales of Tenga products resulted in $838,000 of revenues, a gross margin of $153,000 with an estimated net contribution of $86,000, after expenses. The termination of the Tenga relationship enables us to reallocate warehouse space, sales personnel and employees to focus on expanding the Liberator, Jaxx and Avana brands, which are sold at significantly higher gross margins than Tenga products."
https://www.otcmarkets.com/stock/LUVU/news/Luvu-Brands-Announces-Preliminary-Q2-Fiscal-2017-Results?id=149095&b=y
1c
Recent LUVU News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/20/2024 04:08:13 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/15/2024 01:26:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 08:54:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 07:56:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/16/2023 01:26:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 07:36:35 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM